OBJECTIVE: To define the frequency and timing of breast milk transmission of HIV-1. DESIGN: Meta-analysis of data abstracted from published literature. SUBJECTS: Participants in prospective cohort studies of MTCT of HIV-1. Cohorts were separated on the basis of breast feeding duration. INTERVENTIONS: None. MAIN OUTCOME MEASURES: HIV-1 transmission rates. RESULTS: Two thousand three hundred and seventy five HIV-1 infected women and their infants, 499 of whom breast fed, the estimated risk of breast milk HIV-1 transmission was 16% (95% CI: 9, 22%). Among breastfeeding infants, forty seven per cent of HIV-1 infections were attributable to breast feeding. Breast milk transmission risk was 21% (95% CI: 10, 33%) in cohorts with mean/median duration of breast feeding > or = 3 months and 13% (95% CI: 4, 21%) in cohorts with median duration of breast feeding < 2 months. In a separate analysis of 702 infants with prolonged duration of breast feeding, the risk of late postnatal transmission (infection occurring later than three to six months of age) was four per cent (95% CI 2, 5%). CONCLUSIONS: This analysis suggests that breast milk transmission of HIV-1 is substantial and continues throughout the postnatal period. Early cessation of breast feeding at six months would avert some but not most infant HIV-1 infections due to breast feeding. While recently published studies showing some effectiveness of antiretrovirals early during the breast feeding period are encouraging, prevention of breast milk HIV-1 transmission needs to remain a high research priority.
OBJECTIVE: To define the frequency and timing of breast milk transmission of HIV-1. DESIGN: Meta-analysis of data abstracted from published literature. SUBJECTS:Participants in prospective cohort studies of MTCT of HIV-1. Cohorts were separated on the basis of breast feeding duration. INTERVENTIONS: None. MAIN OUTCOME MEASURES: HIV-1 transmission rates. RESULTS: Two thousand three hundred and seventy five HIV-1 infectedwomen and their infants, 499 of whom breast fed, the estimated risk of breast milk HIV-1 transmission was 16% (95% CI: 9, 22%). Among breastfeeding infants, forty seven per cent of HIV-1 infections were attributable to breast feeding. Breast milk transmission risk was 21% (95% CI: 10, 33%) in cohorts with mean/median duration of breast feeding > or = 3 months and 13% (95% CI: 4, 21%) in cohorts with median duration of breast feeding < 2 months. In a separate analysis of 702 infants with prolonged duration of breast feeding, the risk of late postnatal transmission (infection occurring later than three to six months of age) was four per cent (95% CI 2, 5%). CONCLUSIONS: This analysis suggests that breast milk transmission of HIV-1 is substantial and continues throughout the postnatal period. Early cessation of breast feeding at six months would avert some but not most infantHIV-1 infections due to breast feeding. While recently published studies showing some effectiveness of antiretrovirals early during the breast feeding period are encouraging, prevention of breast milk HIV-1 transmission needs to remain a high research priority.
Authors: Andrew B Wilks; Elizabeth C Christian; Michael S Seaman; Piya Sircar; Angela Carville; Carmen E Gomez; Mariano Esteban; Giuseppe Pantaleo; Dan H Barouch; Norman L Letvin; Sallie R Permar Journal: J Immunol Date: 2010-11-01 Impact factor: 5.422
Authors: Andrew B Wilks; James R Perry; Elizabeth P Ehlinger; Roland C Zahn; Robert White; Marie-Claire Gauduin; Angela Carville; Michael S Seaman; Joern E Schmitz; Sallie R Permar Journal: J Virol Date: 2011-07-06 Impact factor: 5.103
Authors: Sarah A Keim; Kelly A McNamara; Chenali M Jayadeva; Ashlea C Braun; Chelsea E Dillon; Sheela R Geraghty Journal: Matern Child Health J Date: 2014-08
Authors: Francis Bajunirwe; Iyesatta Massaquoi; Stephen Asiimwe; Moses R Kamya; Eric J Arts; Christopher C Whalen Journal: Afr Health Sci Date: 2004-12 Impact factor: 0.927
Authors: Sallie R Permar; Andrew B Wilks; Elizabeth P Ehlinger; Helen H Kang; Tatenda Mahlokozera; Rory T Coffey; Angela Carville; Norman L Letvin; Michael S Seaman Journal: J Virol Date: 2010-06-02 Impact factor: 5.103
Authors: Christine M Rousseau; Ruth W Nduati; Barbra A Richardson; Matthew S Steele; Grace C John-Stewart; Dorothy A Mbori-Ngacha; Joan K Kreiss; Julie Overbaugh Journal: J Infect Dis Date: 2003-02-18 Impact factor: 5.226
Authors: Joshua D Amos; Andrew B Wilks; Genevieve G Fouda; Shannon D Smith; Lisa Colvin; Tatenda Mahlokozera; Carrie Ho; Krista Beck; R Glenn Overman; C Todd DeMarco; Terry L Hodge; Celia C LaBranche; David C Montefiori; Thomas N Denny; Hua-Xin Liao; Georgia D Tomaras; M Anthony Moody; Sallie R Permar Journal: J Virol Date: 2013-08-07 Impact factor: 5.103
Authors: Sallie R Permar; Helen H Kang; Angela Carville; Keith G Mansfield; Rebecca S Gelman; Srinivas S Rao; James B Whitney; Norman L Letvin Journal: J Immunol Date: 2008-09-01 Impact factor: 5.422
Authors: Tatenda Mahlokozera; Helen H Kang; Nilu Goonetilleke; Andrea R Stacey; Rachel V Lovingood; Thomas N Denny; Linda Kalilani; James E G Bunn; Steve R Meshnick; Persephone Borrow; Norman L Letvin; Sallie R Permar Journal: PLoS One Date: 2011-08-23 Impact factor: 3.240